News

Fertility hope for cancer patients

11-Jul-08

Women having cancer treatment could have the chance to preserve their fertility, say German researchers.

They have stimulated ovaries to produce eggs in the final or luteal phase of the menstrual cycle. Until now, ovarian stimulation has been performed in the first part of the cycle, meaning some women would have to wait up to six weeks.

But a pilot study of 40 women has shown success rates if ovarian stimulation is started in the luteal phase. The average time to ovarian stimulation was 11.4 days in this group, compared with 10.3 days in those who had ovarian stimulation in the proliferative phase.

Three quarters of eggs were mature in both groups. A similar proportion were fertilised after intracytoplasmic sperm injection. The research was presented at the European Society of Human Reproduction and Embryology in Barcelona this week.

rachel.liddle@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

The first to face the nMRCGP

Dr Anna Cumisky was in the first cohort of doctors to use the RCGP curriculum and pass the nMRCGP. Read more

nMRCGP Exam Update - Influenza vaccination

Dr Louise Newson is a GP in the West Midlands and author of 'Hot Topics for MRCGP and General Practi... Read more

Consultation skills - Abnormal bereavement reactions

Bereavement reactions can vary but watch out for warning signs, explains Dr Tillman Jacobi. Read more

Show all articles

 

Latest Clinical Articles

Myasthenia gravis

Contributed by Dr Stuart Viegas, neuromuscular clinical research fellow at the John Radcliffe Hospit... Read more

Appendicitis

Contributed by Mr Joe Dawson, specialist registrar in general surgery, Southend University Hospital ... Read more

Ankylosing spondylitis

Contributed by Dr Andrew Cairns, consultant rheumatologist, Musgrave Park Hospital, Belfast. Read more

Show all clinical articles

MIMS Product News

New drug - Toctino

Basilea has launched Toctino (alitretinoin) for the treatment of severe chronic hand eczema (CHE) in... Read more

New drug - Vimpat

UCB Pharma has launched Vimpat (lacosamide) for adjunctive therapy in the treatment of partial-onset... Read more

New drug - Firazyr

Firazyr (icatibant acetate) is indicated for the symptomatic treatment of acute attacks of hereditar... Read more

Jobs

 

Job of the Week